Cochlear Ltd (COH) - Total Assets

Latest as of June 2025: AU$2.83 Billion AUD ≈ $2.00 Billion USD

Based on the latest financial reports, Cochlear Ltd (COH) holds total assets worth AU$2.83 Billion AUD (≈ $2.00 Billion USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Cochlear Ltd - Total Assets Trend (1996–2025)

This chart illustrates how Cochlear Ltd's total assets have evolved over time, based on quarterly financial data. Also see COH stock market capitalisation for the company's overall valuation and market capitalisation.

Cochlear Ltd - Asset Composition Analysis

Current Asset Composition (June 2025)

Cochlear Ltd's total assets of AU$2.83 Billion consist of 50.2% current assets and 49.9% non-current assets. Review COH liabilities breakdown to assess the company's total debt and financial obligations.

Asset Category Amount (AUD) % of Total Assets
Cash & Equivalents AU$275.70 Million 9.8%
Accounts Receivable AU$585.90 Million 20.7%
Inventory AU$499.40 Million 17.7%
Property, Plant & Equipment AU$536.20 Million 19.0%
Intangible Assets AU$222.20 Million 7.9%
Goodwill AU$278.60 Million 9.9%

Asset Composition Trend (1996–2025)

This chart illustrates how Cochlear Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See COH stock price and chart for real-time trading data and today's change.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Cochlear Ltd's current assets represent 50.2% of total assets in 2025, a decrease from 73.0% in 1996.
  • Cash Position: Cash and equivalents constituted 9.8% of total assets in 2025, down from 33.3% in 1996.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 16.0% of total assets, an increase from 0.0% in 1996.
  • Asset Diversification: The largest asset category is accounts receivable at 20.7% of total assets.

Cochlear Ltd Competitors by Total Assets

Key competitors of Cochlear Ltd based on total assets are shown below.

Company Country Total Assets
Medtronic plc
SA:MDTC34
Brazil R$93.03 Billion
Demant A/S
CO:DEMANT
Denmark Dkr39.07 Billion
Medartis Holding AG
SW:MED
Switzerland CHF610.05 Million
Xiangyu Medical Co. Ltd. A
SHG:688626
China CN¥3.27 Billion
L&C Bio Co. Ltd
KQ:290650
Korea ₩497.94 Billion
Beijing Chunlizhengda Medical Instruments Co Ltd
SHG:688236
China CN¥3.54 Billion
PULSION Medical Systems SE
MU:PUS
Germany €35.15 Million
Mediantechn
PA:ALMDT
France €35.87 Million

Cochlear Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 2.35 2.30 1.81
Quick Ratio 1.52 1.68 1.53
Cash Ratio 0.46 0.81 0.69
Working Capital AU$814.50 Million AU$820.60 Million AU$660.00 Million

Cochlear Ltd - Advanced Valuation Insights

This section examines the relationship between Cochlear Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 8.81
Latest Market Cap to Assets Ratio 2.19
Asset Growth Rate (YoY) 2.9%
Total Assets AU$2.83 Billion
Market Capitalization $6.20 Billion USD

Valuation Analysis

Premium Asset Valuation: The market values Cochlear Ltd's assets at a significant premium (2.19x), suggesting investors see substantial growth potential or unique competitive advantages.

Positive Asset Growth: Cochlear Ltd's assets grew by 2.9% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Cochlear Ltd (1996–2025)

The table below shows the annual total assets of Cochlear Ltd from 1996 to 2025.

Year Total Assets Change
2025-06-30 AU$2.83 Billion
≈ $2.00 Billion
+2.91%
2024-06-30 AU$2.75 Billion
≈ $1.94 Billion
+6.87%
2023-06-30 AU$2.57 Billion
≈ $1.82 Billion
+4.20%
2022-06-30 AU$2.47 Billion
≈ $1.74 Billion
+1.61%
2021-06-30 AU$2.43 Billion
≈ $1.72 Billion
-6.08%
2020-06-30 AU$2.58 Billion
≈ $1.83 Billion
+87.29%
2019-06-30 AU$1.38 Billion
≈ $975.87 Million
+19.22%
2018-06-30 AU$1.16 Billion
≈ $818.58 Million
+1.81%
2017-06-30 AU$1.14 Billion
≈ $804.00 Million
+18.69%
2016-06-30 AU$957.36 Million
≈ $677.40 Million
+9.36%
2015-06-30 AU$875.40 Million
≈ $619.40 Million
+10.95%
2014-06-30 AU$789.04 Million
≈ $558.29 Million
+3.21%
2013-06-30 AU$764.50 Million
≈ $540.93 Million
+8.82%
2012-06-30 AU$702.54 Million
≈ $497.09 Million
-5.20%
2011-06-30 AU$741.05 Million
≈ $524.34 Million
-1.42%
2010-06-30 AU$751.72 Million
≈ $531.89 Million
+10.65%
2009-06-30 AU$679.37 Million
≈ $480.70 Million
+11.75%
2008-06-30 AU$607.92 Million
≈ $430.14 Million
+3.79%
2007-06-30 AU$585.74 Million
≈ $414.45 Million
+7.29%
2006-06-30 AU$545.92 Million
≈ $386.28 Million
+7.94%
2005-06-30 AU$505.75 Million
≈ $357.85 Million
+91.18%
2004-06-30 AU$264.54 Million
≈ $187.18 Million
+14.73%
2003-06-30 AU$230.58 Million
≈ $163.15 Million
+43.73%
2002-06-30 AU$160.43 Million
≈ $113.51 Million
+24.32%
2001-06-30 AU$129.05 Million
≈ $91.31 Million
+37.62%
2000-06-30 AU$93.77 Million
≈ $66.35 Million
+13.06%
1999-06-30 AU$82.94 Million
≈ $58.68 Million
+20.00%
1998-06-30 AU$69.11 Million
≈ $48.90 Million
+34.76%
1997-06-30 AU$51.29 Million
≈ $36.29 Million
+6.31%
1996-06-30 AU$48.24 Million
≈ $34.13 Million
--

About Cochlear Ltd

AU:COH Australia Medical Devices
Market Cap
$6.20 Billion
AU$8.76 Billion AUD
Market Cap Rank
#3121 Global
#69 in Australia
Share Price
AU$133.90
Change (1 day)
-1.83%
52-Week Range
AU$90.00 - AU$296.20
All Time High
AU$345.53
About

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor… Read more